Page last updated: 2024-11-10

methyldithiocarbazate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyldithiocarbazate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3034069
SCHEMBL ID10117732
SCHEMBL ID1229894
MeSH IDM0066670

Synonyms (27)

Synonym
nsc4423
nsc-4423
s-methyl dithiocarbazate
5397-03-5
dithiocarbazic acid methyl ester
methyl hydrazinecarbodithioate
hydrazinecarbodithioic acid, methyl ester
methyl dithiocarbazate
carbazic acid, dithio-, methyl ester
methyldithiocarbazate
methyl n-aminocarbamodithioate
AKOS006220764
nsc 4423
ai3-22502
hydrazinecarbodithioic acid methyl ester
SCHEMBL10117732
DTXSID3063835
SCHEMBL1229894
GS-1932
{[(methylsulfanyl)methanethioyl]amino}amine
mfcd00463356
methylhydrazinecarbodithioate
A856889
EN300-43242
R2L2YRR7MP
([(methylsulfanyl)methanethioyl]amino)amine
F71622
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]